Texas Attorney General Takes Legal Action Against Acetaminophen Makers Concerning Autism Spectrum Claims
The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, alleging the companies hid safety concerns that the medication created to children's brain development.
This legal action comes four weeks after Former President Trump advocated an unverified association between taking acetaminophen - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.
The attorney general is filing suit against J&J, which once produced the drug, the sole analgesic recommended for pregnant women, and Kenvue, which now manufacturers it.
In a statement, he stated they "misled consumers by gaining financially from discomfort and promoting medication regardless of the risks."
The manufacturer asserts there is no credible evidence connecting acetaminophen to autism.
"These companies misled for generations, deliberately risking countless individuals to increase profits," Paxton, a Republican, said.
Kenvue stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the health of US mothers and children."
On its online platform, Kenvue also stated it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a proven link between consuming paracetamol and autism."
Groups speaking for physicians and medical practitioners concur.
The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to address pain and fever, which can present significant medical dangers if ignored.
"In more than two decades of investigation on the use of paracetamol in gestation, no reliable research has definitively established that the consumption of paracetamol in any trimester of gestation results in brain development issues in young ones," the group commented.
This legal action mentions latest statements from the Trump administration in asserting the medication is potentially dangerous.
Last month, Trump caused concern from public health officials when he instructed pregnant women to "resist strongly" not to use Tylenol when unwell.
The FDA then released a statement that doctors should consider limiting the use of acetaminophen, while also stating that "a direct connection" between the medication and autism in minors has not been established.
The Health Department head RFK Jr, who supervises the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would identify the cause of autism in a short period.
But experts cautioned that finding a single cause of autism spectrum disorder - considered by experts to be the outcome of a complex mix of genetic and surrounding conditions - would be difficult.
Autism spectrum disorder is a form of lifelong neurodivergence and condition that impacts how individuals experience and engage with the surroundings, and is identified using physician assessments.
In his court filing, the attorney general - aligned with the former president who is seeking federal office - asserts the manufacturer and J&J "deliberately disregarded and tried to quiet the science" around paracetamol and autism spectrum disorder.
This legal action attempts to require the firms "eliminate any commercial messaging" that asserts acetaminophen is safe for pregnant women.
The court case mirrors the complaints of a collection of mothers and fathers of children with autism spectrum disorder and ADHD who sued the producers of acetaminophen in recently.
Judicial authorities threw out the case, saying studies from the parents' expert witnesses was inconclusive.
